Trial & Signal Intelligence

Search trials, monitor signals, and review source-aware summaries in one workflow.

FeazAI turns public trial registry data and source-anchored public signals into structured intelligence — without hype, speculation, or promotional framing.

AI where it helps. Source context where it matters.

iOS app in App Store review. Android coming soon.

Source · Public registries & public signals
01

Trial Search

Query public trial registries with structured filters and registry-aware source selection.

02

Dashboard Analytics

Aggregate counts, phase distribution, sponsor coverage, and geography at a glance.

03

Signals & Watchlist

Monitor sponsor activity from public signals with scored, category-level breakdowns.

04

Weekly Brief

Structured weekly summaries anchored to source-linked public disclosures and readouts.

05

Smart Match

AI-assisted trial similarity analysis, with confidence and the reasoning made explicit.

01 — Explore

Search public trial registries.

One structured entry point to ClinicalTrials.gov and the EU Register. Refine by registry, status, phase, country, and sponsor. Move fluidly from a broad query to a focused results list.

  • i.Registry-aware — choose CT.gov, EU Register, or both from a single control.
  • ii.Structured filters — clean facets that compose instead of overwhelming.
  • iii.Results with context — source, identifier, phase, and sponsor surfaced per trial.
Results list
Explore screen
02 — Overview

From search to structured overview.

Every query opens into a calm, analytical surface: aggregate counts, ongoing and planned volumes, geography, and sponsor distribution — alongside a consistent trial detail view for deep reads.

  • i.Aggregate view — total trials, ongoing and planned, countries, sponsors.
  • ii.Consistent detail — source-anchored fields with registry links.
  • iii.Top-sample aware — structured sampling where datasets are large.
Trial detail
Dashboard analytics
03 — Signals

Monitor sponsor activity from public signals.

Sponsors you track are scored across categories — trial registrations, phase transitions, status changes, and public disclosures — with score drivers surfaced transparently, not as a black box.

  • i.Watchlist — organise sponsors by therapeutic area and time window.
  • ii.Activity breakdown — per-category scores with source-linked drivers.
  • iii.Source-anchored — every score traces back to a public reference.
Activity detail
Watchlist
04 — Synthesis

Structured summaries and AI-assisted similarity.

Weekly briefs are generated from recent source-anchored public signals with explicit confidence. Smart Match surfaces related trials alongside an anchor, with the reasoning and key differences made legible.

  • i.Weekly Brief — curated, structured, anchored to public readouts and disclosures.
  • ii.Smart Match — related-trial analysis with a confidence signal.
  • iii.Explicit reasoning — why a match was drawn, where it diverges.
Weekly Brief detail
Smart Match
Why FeazAI

A calm, source-aware surface across trials and signals.

For professionals, researchers, investors, and curious readers who want a grounded view of public trial and sponsor activity.

Built for anyone who wants structured public pharma intelligence without hype, speculation, or promotional spin.

i.

One workflow

Search, analytics, monitoring, briefs, and similarity in a single, coherent surface.

ii.

Public information

Built on registries and public disclosures. No private data, no proprietary claims.

iii.

Source-aware

Every figure, score, and summary carries its source. Transparency as a design choice.

iv.

Calm by design

Typographic restraint, structural clarity. Built for reading, not for demanding attention.

Approach

Designed around public registries and public source monitoring, FeazAI emphasizes structure, visibility, and analytical clarity — not promotion, prediction, or clinical claims.

Public by default

Working set is drawn from ClinicalTrials.gov, the EU Register, and public disclosures.

Neutral framing

No endorsement of sponsors or therapies. Content is presented analytically, not promotionally.

Explicit confidence

AI-assisted analysis is labelled with confidence and accompanied by the reasoning behind it.

Early access

Join the FeazAI waitlist.

iOS app in App Store review. Android coming soon.

We respect your inbox. No marketing lists, no third-party sharing.